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A subset of omphalocele infants has respiratory decompensation after the ﬁrst week of life and PHN is
diagnosed. Infection may initiate decompensation. In some, PHN is distinct from pulmonary hypoplasia
as they oxygenate on room air for some time after birth. With aggressive treatment and follow-up, PHN
can resolve. The late diagnosis of PHN in infants with omphalocele is previously unappreciated and
deserves further study.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).An omphalocele is a ventral defect of the umbilical ring with
herniation of the abdominal viscera [1]. For omphalocele infants,
respiratory failure at birth is an independent predicator of mortality
[2]. Pulmonary hypoplasia, deﬁned as incomplete lung develop-
ment, with decreased broncho-pulmonary segments and dimin-
ished alveolar septation, may contribute to respiratory insufﬁciency
after birth in some, but not all, omphalocele infants [3]. Pulmonary
hypertension (PHN), diagnosed between the second and seventh
day after birth, is an independent predictor of mortality in
omphalocele infants and may represent another cause of respira-
tory insufﬁciency [4,5].
A subset of omphalocele infants has no evidence of pulmonary
hypoplasia or hypertension at birth, but exhibit respiratory insufﬁ-
ciencyafter theﬁrstweekof life. These infantsmayhavea latediagnosis
of PHN. Although respiratory insufﬁciency is considered an important
factor in omphalocele outcomes, little is known about this entity.
We report six infants with an omphalocele and a late diagnosis
of pulmonary hypertension. On the basis of the ﬁndings of these
cases and a literature review, strategies to promote recognition and
treatment of this entity are discussed.111 Coleman Pavilion, 11175
Published by Elsevier Inc. This is a1. Materials and methods
After Institutional Review Board approval, a retrospective re-
view was performed of 115 infants born with omphalocele at two
academic children’s hospitals between 2000 and 2011. Fifty-eight
were excluded because an echocardiogram was performed on the
ﬁrst day of life, during the phase of transitional circulation. No other
echocardiograms were performed in these 58. In 51, PHN was
diagnosed between day of life two and seven and they were
excluded. The six included infants had a diagnosis of PHN after the
ﬁrst week of life.
Infant demographic data, cardiopulmonary status at birth,
clinical deterioration, laboratory septic markers, culture data, B-
type natriuretic peptide (BNP) levels, transthoracic echocardio-
grams, and clinical outcomes were recorded. Prenatal ultrasound
and magnetic resonance imaging (MRI) reports were sought in the
medical records.
The initial preoperative transthoracic echocardiograms were
obtained. After recording the initial reports, a single cardiologist
interpreted each one in blinded fashion, to eliminate reviewer
variability in the diagnosis of PHN. Pulmonary hypertension
was deﬁned as ﬂattening of the inter-ventricular septum during
systole and/or a tricuspid regurgitant jet (TR) with an estimated
right ventricular pressure greater than 40 mm when observed
in the setting of hypoxemia [6]. The omphalocele defect wasn open access article under the CC BY-NC-ND license (http://creativecommons.org/
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the sac [1].
A search of the published literature pertaining to omphalocele
and pulmonary hypertension was performed using the PubMed
online database. The language was limited to English, but year of
publication was not limited.
2. Results
Demographic data are presented in Table 1. There were three
females and three males born between 35 and 39weeks gestational
age. The median gestational age was 37.5 weeks, the median birth
weight was 2502 g and the medianweight/length z-score was 0.53.
All were prenatally diagnosed by ultrasound and four met the
criteria for giant omphalocele. None had prenatal MRI imaging
available for review. All had normal chromosomal studies and no
evidence of aneuploidy.
Infant cardiopulmonary data at birth and during the ﬁrst week
of life are presented in Table 2. All six infants maintained an oxygen
saturation of 100% on the ﬁrst day of life. Three were breathing
room air. Three required intubation at birth and conventional me-
chanical ventilation. The sixth infant was extubated and breathing
room air between DOL 3 and 15.
Three infants required no cardiopulmonary support at birth and
nippled their feeds between day of life three and six. Three infants
that required ventilator support at birth, tolerated gavage or
nasojejunal (NJ) feeds between day of life 2 and 46. Infants one and
three were diagnosed with Fryn and Goltz Syndrome, respectively.
Four had a transthoracic echo on day of life two and two on day
of life three. All were initially diagnosed as having no pulmonary
hypertension. A blinded retrospective review of the initial echo-
cardiogram tapes by one cardiologist for this series, found subtle
signs of PHN in four infants (Table 2). All congenital heart defects
were simple, non-ductal dependent anomalies without hemody-
namic signiﬁcance.
Cardiopulmonary function deteriorated in all six infants
(Table 3). Further investigations, imaging and treatment proceeded
according to clinician speciﬁc practice. All six infants had laboratory
studies consistent with infection from culture proven urosepsis,
bacteremia or pneumonia, on the day of deterioration.
Transthoracic echocardiography was performed between DOL 9
and 52 (median: DOL 15), and revealed PHN in all six. One under-
went computed tomography angiography (CT-angio) on DOL 20.
The fourth infant deteriorated with sepsis in the second week of
life, and the PHN persisted. This was appreciated when she un-
derwent a CT angio and cardiac catheterization (cath) on DOL 117
and was found to have severe PHN. The CT angio revealed a struc-
turally normal heart in each infant.
Treatment of sepsis was broad spectrum antibiotics in all six
cases which was subsequently guided by available culture results.
Treatment of PHN in all six included nitric oxide, sildenaﬁl,
inotropes (dopamine and dobutamine) and milrinone (Table 3).Table 1
Demographics of six infants with omphalocele and a late diagnosis of PHN.
Gender Gestational age
(weeks)
Birth
weight (g)
Weight/length
z-score at birth
Inborn Giant defe
F 35 2644 0.53 No No
M 39 3775 0.55 Yes Yes
F 39 2325 0.28 No No
F 37 2448 1.5 Yes Yes
M 35 2555 0.75 No Yes
M 38 2299 0.53 No YesAll infants received paralytics with vecuronium and sedation
with narcotics and versed to promote better ventilation during
escalation of treatment. The results of any BNP levels were sought
in the medical records, but none were obtained. The third infant
received Esmolol for supraventricular tachycardia (SVT) that
occurred when she was septic.
The three that required conventional ventilation at birth, esca-
lated to high frequency oscillatory ventilation (HFOV) (infants 4e6).
When respiratory failure worsened in the sixth infant, a decision
was made for veno-venous ECMO.
Infant outcomes are presented in Table 4. All three mortalities
died within two months after birth at a median of 22 days (range:
18e51 days). All had severe PHN at the time of death and none
responded to aggressive treatment for PHN and sepsis. None were
stable for repair of the omphalocele defect. One suffered an
omphalocele sac rupture and was debrided several days before his
demise and one died on ECMO.
The sixth infant developed persistent tachycardia on DOL 13 and
was intubated emergently on DOL 14. An endotracheal tube culture
was positive for Group B streptococcus. Despite HFOV and an Fi02 of
100%, his respiratory failure worsened. An echocardiogram
conﬁrmed severe PHN. The infant was placed on veno-venous
ECMO on DOL 15.
The decision for veno-venous ECMO was based on the fact that
the infant had been extubated and ventilating well during the ﬁrst
week of life. Review of the literature revealed a paucity of data to
guide the clinical management. It appeared the new-onset of PHN
may respond to oxygenation and sepsis treatment. Within 24 h,
the infant developed circuit disseminated intravascular coagula-
tionwith platelet consumption, combined with clots in the arterial
side of the circuit. A complete circuit change was done. Serial
echocardiograms revealed worsening PHN, and clots in the right
ventricle extending through the tricuspid valve. Due to worsening
PHN and ECMO complications, a recommendation was made to
withdraw care and the infant died on the third day of ECMO
support (DOL 18).
Follow-up for three survivors ranged from 540 to 1219 days
with a median of 868 days. Follow-up echocardiograms revealed
the PHN resolved for all three, and they are tolerating full enteral
feeds. Two have tracheostomies and require support for chronic
respiratory insufﬁciency. Infants 3 and 4 have mild neurologic
impairment.
Infant 3 underwent a primary omphalocele repair on DOL 38.
One week after repair, the infant returned to the operating room for
a bowel obstruction with perforation. The infant required a bowel
resection, but recovered and was discharged from hospital on DOL
59. There was no clinically signiﬁcant PHN at this time. Sildenaﬁl
was discontinued before discharge.
Prior to discharge, this infant was diagnosed by skin biopsy with
Goltz syndrome, a craniofacial syndrome (facial dermal hypopla-
sia). The infant had a cleft lip, a club foot and syndactyly. A brain
MRI revealedmild frontal/temporal lobe atrophy, and bilateral opticct Age at diagnosis by
prenatal US (weeks)
Prenatal US report, omphalocele contents
and heart evaluation
16 Small bowel, hydronephrosis, two vessel cord, ASD
18 Liver, small bowel, stomach, polyhydramnios,
normal heart
20 Small bowel, small VSD
22 Liver, large and small bowel, hydronephrosis,
oligohydramnios, Prominent Right atrium
20 Liver, large and small bowel, small ASD
12 Liver, small bowel, stomach, normal heart
Table 2
Infant cardiopulmonary status at birth and during the ﬁrst week of life.
Apgar 1 min Apgar 5 min Intubated at birth Fi02 at birth (%)a Initial echo report Blinded echo
review
Echo: CHD DOLc ﬁrst feeding Genetic syndrome
8 9 No 21 No PHN Mild PHN Dextrocardia
Small ASD
3 Fryn syndrome
8 8 No 21 No PHN No PHN Normal 3
8 9 No 21 No PHN Mild PHN Small VSD 6 Goltz syndrome with cleft lip
1 7 Yes Conv vent
55
No PHN Mild PHN Normal 46 (NJ feed)
3 8 Yes Conv vent
40
No PHN No PHN Small ASD 2 (gavage)
8 5 Yes Conv vent
30
Extb DOL 3e15
No PHN Mild PHN Small PFO 7 (gavage)
a Infants 1e3 breathed room air at birth.
b Extubated.
c Infants 1e3 nippled feedings.
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abnormal. She failed her hearing test due to conductive hearing loss
in the left ear. She required a gastrostomy tube for feeding. She was
followed by neurology every three months and attended early
physiotherapy and speech therapy.
At 19 months, she was walking with assistance, eating inde-
pendently with a spoon and speaking several words. Her follow-up
EEG was normal. At 10 years she attended regular school and had
mild cognitive, motor, speech and hearing deﬁcits. She has no
respiratory difﬁculties.
Infant 4 has a giant omphalocele and repair is pending. This
infant was diagnosed with PHN on ECHO at DOL 13 when she
deteriorated with sepsis, and underwent tracheostomy for chronic
lung disease at DOL 71. However, her persistent PHN was better
appreciated by clinicians after she underwent cardiac catheteri-
zation at DOL 171. At the time of catheterization, she required
100% Fi02 and nitric oxide at 20 ppm. Her prognosis was consid-
ered very poor and her status was “do not resuscitate”.
After the catheterization conﬁrmed severe PHN, she began long-
term sildenaﬁl and Bosentan therapy. By ten months, her Fi02
decreased to 25% and nitric oxide was discontinued. Serial echo-
cardiograms guided the weaning of sildenaﬁl. She was discharged
to a chronic care facility at 10 months. At 2 years of age, after the
PHN had improved, she underwent an open left thoracic CDH repair
for a previously undiagnosed CDH and recovered well. At 3 years,Table 3
Cardiopulmonary, sepsis, ventilation and inotrope data at deterioration.
Intubated DOL Fi02a ECHO DOL Blood gas:
base excess
Culture result
12b 40 18 4 Urine
Enterobacter
9 75 9 5 Blood
Methicillin resistant Staph
4 40 15 3 Blood
Coagulase negative
Staph
Intubated at birthc HFOV
60
13 9 Trachea
Staph aureus
(pneumonia)
Intubated at birth HFOV
65
52 5 Blood
Coagulase negative
Staph
Intubated at birth HFOV
100
15 2 Trachea
Group B Strep
(pneumonia)
a Infants 1e3 placed on conventional ventilation.
b CT Angio on DOL 20.
c CT Angio and Cardiac Cath on DOL 117.
d Supraventricular tachycardiashe has mild PHN on echocardiogram, her Fi02 is 21% and she
continues to take sildenaﬁl. Her Bosentan was discontinued. Her
pulmonary function studies are consistent with restrictive lung
disease.
At 10 months of age, before hospital discharge, this infant un-
derwent a brain MRI which revealed hypoxic ischemic encepha-
lopathy (HIE). She required full gastrostomy tube feeds, had motor,
cognitive and speech delays, and could sit with assistance, but
appeared to track and hear normally. She was followed by
neurology every 3 months and received physio and speech therapy.
By 2 years, shewas walking with assistance, and has onlymild gross
motor and cognitive delays.
Infant 5 underwent staged repair with complete closure of the
omphalocele on DOL 151 and no other operations were performed.
Sildenaﬁl was discontinued before discharge. The child was dis-
charged with a tracheostomy but no further long-term follow-up
neurologic or respiratory evaluations were available.
3. Discussion
Respiratory insufﬁciency is a known complication in infants
with an omphalocele, but the causes are not well understood [1].
Omphalocele infants with MR imaging-based observed/expected
total fetal lung volumes (O/E TFLV) below 50% have signiﬁcantly
lower Apgar scores and prolonged ventilation [7]. This ﬁnding isWBC/CRP Vent (days) Inotropes (days) Milrinone and
other (days)
11/4 10 4 4
22 w bands/24 42 8 10
19/20 6 4 Esmolol
SVTd on DOL 15
12/17 868 (trach DOL 71) 10 11
19/16 200 (trach DOL 52) 5 5
18/18.4 4 (V-V ECMO) 3 3
Table 4
Outcomes and day of life (DOL) follow-up (F/U) evaluation.
Outcome
DOL F/U
Last echo
DOL
Medication
respiratory status
Neurologic status at
hospital d/c (MRI results)
Omphalocele Repairs
DOL
Feeding status at F/U Other operations
DOL
Died
22
Sepsis
PHN
22
Fi02 100% Not repaired NPO
Died
51
Sepsis
PHN
48
Fi02 100% Not repaired NPO Sac rupture-debrided
46
Alive
1219
No PHN
30
No meds
Room air
Frontal lobe
atrophy
Primary and G-tube
38
Full G-tube feeds SBO,b malrotation, perforation
45
Alive
868
No PHN
727
Sildenaﬁl Fi02 25% HIEa
Motor and cognitive
delay
Not repaired Full NJ feeds Left CDHc repair
800
Alive
540
No PHN
100
No meds
Room air
Staged
Final 151
Nippling full feeds
Died
18
Sepsis
PHN
17
V-V ECMO Not repaired NPO
a Hypoxic ischemic encephalopathy (HIE).
b Small bowel obstruction (SBO).
c Congenital diaphragmatic hernia (CDH).
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locele infants. These measurements represent incomplete lung
development (pulmonary hypoplasia) which may contribute to
respiratory insufﬁciency in some omphalocele infants, but is not a
complete explanation. In this setting, a ﬁxed respiratory insufﬁ-
ciency exists at birth.
In contrast, four infants in our series experienced little inﬂuence
from pulmonary hypoplasia. They ventilated well on room air at
birth, had satisfactory Apgar scores and nippled their ﬁrst feedings,
including one that subsequently required ECMO support.
A mortality rate as high as 25% is reported for omphalocele in-
fants [1]. Pulmonary hypertension (PHN) is associated with mor-
tality in omphalocele infants, independent of pulmonary
hypoplasia or other causes, but few studies exist [4].
Pulmonary hypertension is an independent risk factor for mor-
tality in infants with late-onset sepsis [8]. The mortality rate for
infants with sepsis is between 7 and 12% and increases if PHN de-
velops. Group B streptococcus sepsis also carries a high risk of
complications from the development of PHN [9]. Three infants in
this series with risk factors for mortality died. All had sepsis, PHN,
one suffered a sac rupture and one was culture positive for Group B
streptococcus.
The explanation for worsening PHN in omphalocele infants re-
mains unknown. In some, isolated PHN in the absence of a CHD has
been documented on prenatal echocardiogram [10]. The developing
lung is subject to multiple genetic, pathological and environmental
inﬂuences that can adversely affect development leading to PHN.
New classiﬁcations of PHN may account for this diversity such as
maladaptation, excessive muscularization and remodeling, and
vascular hypoplasia as observed in CDH [11]. One infant responded
well to long-term sildenaﬁl and Bosentan, an endothelin receptor
antagonist that improves pulmonary vascular resistance through
remodeling. This favorable response implies a component of mus-
cularization may contribute to PHN in omphalocele infants. Recent
experience suggests Bosentan is well-tolerated and effective for
pediatric PHN [12].
All six infants had culture proven evidence of sepsis, wors-
ening acidosis, elevation of inﬂammatory markers and escalation
of cardiopulmonary support. Echocardiograms performed at
deterioration conﬁrmed signiﬁcant PHN. Although this is a small
retrospective series, it reveals an important, previously unre-
ported pattern, of worsening PHN with sepsis in omphalocele
infants.One infant died after three days of veno-venous ECMO support
at eighteen days of age. Review of the ELSO database revealed only
eleven infants with omphalocele was placed on ECMO, all for PHN,
and all since 2011 [13]. Veno-arterial ECMOwas used for all but one,
and seven (64%) were weaned from ECMO, but only two (18%)
survived to discharge. Four of eleven in the ELSO series had a CDH in
addition to an omphalocele. One infant in this series had ompha-
locele, severe PHN and a late-diagnosed CDH. Multiple factors may
inﬂuence the developing lung and etiology of PHN.
Pulmonary hypertension is more commonly reported in giant
omphalocele infants [5]. However, three infants in this series met
the deﬁnition of non-giant omphalocele and one died. In a recent
series, 28 omphalocele infants had PHN but only 17 (61%) met the
deﬁnition of a giant defect, 11 (39%) were diagnosed with PHN
by strict criteria, and had a non-giant omphalocele [4]. The fact
that PHN occurs with non-giant omphaloceles merits further
investigation.
The association of PHN with mortality in omphalocele infants
is only recently appreciated. Associations for both PHN and
omphalocele, and PHN and sepsis, are reported [4,5,8]. When
these combined diagnoses exist, PHN should be sought and
treated. Echocardiography should be performed after the second
day of life, to allow resolution of the transitional circulation, and
repeated if respiratory status worsens. Serial monitoring of in-
ﬂammatory markers and markers of worsening right heart func-
tion may allow early detection and treatment of worsening PHN
and/or sepsis.
Serial biomarkers such as B-type natriuretic peptide (BNP) have
revealed prognostic value in PHN and serum levels decrease with
functional improvement [14]. Measures of BNP levels provide a
biomarker that differentiates infants with PHN physiology from
those with pulmonary causes of respiratory failure and monitors
worsening right heart function [11]. No BNP levels were obtained in
this retrospective series, but as awareness of PHN grows, serial BNP
levels should be part of a PHN care strategy in omphalocele infants.
The detection of delayed PHN should be aggressively managed
as suggested by this series where only 50% survived despite treat-
ment with nitric oxide, sildenaﬁl andmilrinone, escalating to ECMO
in one case. One received the endothelin-receptor antagonist,
Bosentan and sildenaﬁl, for over one year and recovered. Since
multiple mechanisms are involved in the pathogenesis of PHN, drug
combinations with different sites of action should be considered in
its management [15].
J.E. Baerg et al. / J Ped Surg Case Reports 15 (2016) 14e1818Follow-up echocardiograms revealed PHN resolved in the three
survivors, which implies a reversible phenomenon. If successfully
supported, an infant may survive. Whether the non-survivors
developed irreversible physiology is unknown, but based on these
infants, one should consider every option in the armamentarium
for treating PHNwhen it appears later in the course of omphalocele
infants.
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